• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRAF3 通过调节致癌蛋白 Pim2 和 c-Myc 来抑制正常和恶性 B 细胞的存活。

TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.

机构信息

Department of Microbiology & Immunology, University of Iowa, Iowa City, IA, USA.

Immunology Graduate Program, University of Iowa, Iowa City, IA, USA.

出版信息

Sci Rep. 2019 Sep 9;9(1):12884. doi: 10.1038/s41598-019-49390-9.

DOI:10.1038/s41598-019-49390-9
PMID:31501481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6733949/
Abstract

TRAF3 is a versatile intracellular adapter protein with multiple context-specific roles. Uniquely in B cells, TRAF3 deficiency enhances survival and increases the risk of transformation, as loss of TRAF3 is observed in several types of B cell cancers. Here, we report a new mechanism for TRAF3 in the restraint of B cell survival. We found that TRAF3 deficiency was associated with induction of the pro-survival kinase Pim2 in mouse primary B cells and human malignant B cell lines. The increase in Pim2 was independent of NF-κB2 activation but was ameliorated with inhibition of STAT3 expression or function. TRAF3 deficiency also led to a Pim2-dependent increase in c-Myc protein levels and was associated with reduced c-Myc ubiquitination. TRAF3-deficient primary B cells were less sensitive to cell death induced by the Pim inhibitors SGI-1776 and TP-3654. Interestingly, human malignant B cell lines with low expression of TRAF3 were more sensitive to Pim inhibition-induced cell death. Combination treatment of TRAF3-deficient B cells and B cell tumor lines with c-Myc inhibitors enhanced their sensitivity to Pim inhibition, suggesting a possible therapeutic strategy. TRAF3 thus suppresses a Pim2-mediated B cell survival axis, which can be a potential target for treatment of B cell malignancies.

摘要

TRAF3 是一种多功能的细胞内衔接蛋白,具有多种特定于上下文的作用。在 B 细胞中独一无二的是,TRAF3 缺乏会增强存活并增加转化的风险,因为几种类型的 B 细胞癌中都观察到 TRAF3 的缺失。在这里,我们报告了 TRAF3 抑制 B 细胞存活的一种新机制。我们发现,TRAF3 缺乏与在小鼠原代 B 细胞和人恶性 B 细胞系中诱导生存激酶 Pim2 的表达有关。Pim2 的增加独立于 NF-κB2 的激活,但可通过抑制 STAT3 的表达或功能得到改善。TRAF3 缺乏还导致 Pim2 依赖性 c-Myc 蛋白水平增加,并与 c-Myc 泛素化减少有关。TRAF3 缺陷的原代 B 细胞对 Pim 抑制剂 SGI-1776 和 TP-3654 诱导的细胞死亡的敏感性降低。有趣的是,TRAF3 表达水平低的人恶性 B 细胞系对 Pim 抑制诱导的细胞死亡更为敏感。用 c-Myc 抑制剂联合治疗 TRAF3 缺陷的 B 细胞和 B 细胞肿瘤系增强了它们对 Pim 抑制的敏感性,提示了一种可能的治疗策略。因此,TRAF3 抑制了 Pim2 介导的 B 细胞存活轴,这可能是治疗 B 细胞恶性肿瘤的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/9c6af3552796/41598_2019_49390_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/8aea785e63d7/41598_2019_49390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/de19ac4b51e9/41598_2019_49390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/c157095bc2d5/41598_2019_49390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/358df507af63/41598_2019_49390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/c90672e03046/41598_2019_49390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/a73b649805d9/41598_2019_49390_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/9c6af3552796/41598_2019_49390_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/8aea785e63d7/41598_2019_49390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/de19ac4b51e9/41598_2019_49390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/c157095bc2d5/41598_2019_49390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/358df507af63/41598_2019_49390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/c90672e03046/41598_2019_49390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/a73b649805d9/41598_2019_49390_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d116/6733949/9c6af3552796/41598_2019_49390_Fig7_HTML.jpg

相似文献

1
TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.TRAF3 通过调节致癌蛋白 Pim2 和 c-Myc 来抑制正常和恶性 B 细胞的存活。
Sci Rep. 2019 Sep 9;9(1):12884. doi: 10.1038/s41598-019-49390-9.
2
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.N-苄基阿霉素-14-戊酸酯(AD 198)对TRAF3缺陷型小鼠B淋巴瘤和人多发性骨髓瘤表现出强大的抗肿瘤活性。
BMC Cancer. 2013 Oct 16;13:481. doi: 10.1186/1471-2407-13-481.
3
Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.PIM2缺失增强了泛PIM激酶抑制剂AZD1208在非霍奇金淋巴瘤中的抗增殖作用。
Mol Cancer. 2015 Dec 8;14:205. doi: 10.1186/s12943-015-0477-z.
4
TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.肿瘤坏死因子受体相关因子 3 抑制正常和恶性 B 细胞中的 B 细胞受体信号转导。
J Biol Chem. 2021 Jan-Jun;296:100465. doi: 10.1016/j.jbc.2021.100465. Epub 2021 Feb 25.
5
TRAF3 deficiency promotes metabolic reprogramming in B cells.TRAF3 缺乏促进 B 细胞的代谢重编程。
Sci Rep. 2016 Oct 18;6:35349. doi: 10.1038/srep35349.
6
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.直接的Myc靶点Pim3与其他Pim激酶协同作用,以维持Myc诱导的B细胞淋巴瘤的生存能力。
Oncotarget. 2011 Jun;2(6):448-60. doi: 10.18632/oncotarget.283.
7
Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC.PIM2 对 USP27X 的磷酸化通过去泛素化 MYC 促进糖酵解和乳腺癌进展。
Oncogene. 2024 Aug;43(33):2493-2503. doi: 10.1038/s41388-024-03097-y. Epub 2024 Jul 5.
8
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).PIM 激酶对于慢性淋巴细胞白血病细胞的存活(PIM2/3)和 CXCR4 介导的微环境相互作用(PIM1)是必不可少的。
Mol Cancer Ther. 2014 May;13(5):1231-45. doi: 10.1158/1535-7163.MCT-13-0575-T. Epub 2014 Mar 21.
9
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.丝氨酸/苏氨酸激酶 Pim-2 是骨髓瘤细胞中一种新型的抗凋亡介质。
Leukemia. 2011 Jul;25(7):1182-8. doi: 10.1038/leu.2011.60. Epub 2011 Apr 8.
10
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.核输出选择性抑制剂(SINE)XPO1拮抗剂KPT-185对核糖体生物合成和翻译通量的抑制作用
PLoS One. 2015 Sep 4;10(9):e0137210. doi: 10.1371/journal.pone.0137210. eCollection 2015.

引用本文的文献

1
Reduction of TRAF3 by heterozygosity or aging impacts B cell function.杂合性或衰老导致的TRAF3减少会影响B细胞功能。
Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2507217122. doi: 10.1073/pnas.2507217122. Epub 2025 Aug 7.
2
Effects of TRAF3 on the proliferation and migration of lung adenocarcinoma depend partly on pyroptosis.肿瘤坏死因子受体相关因子3(TRAF3)对肺腺癌增殖和迁移的影响部分取决于细胞焦亡。
BMC Cancer. 2023 Oct 5;23(1):942. doi: 10.1186/s12885-023-11468-z.
3
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.

本文引用的文献

1
TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.TRAF3 作为 B 淋巴细胞存活和激活的多功能调节因子。
Front Immunol. 2018 Sep 24;9:2161. doi: 10.3389/fimmu.2018.02161. eCollection 2018.
2
Genetic Alterations of TRAF Proteins in Human Cancers.肿瘤坏死因子受体相关因子蛋白在人类癌症中的遗传改变。
Front Immunol. 2018 Sep 20;9:2111. doi: 10.3389/fimmu.2018.02111. eCollection 2018.
3
Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.意义未明的IgM单克隆丙种球蛋白病的认识进展
TRAF2/3 缺陷的 B 细胞通过 NF-κB2/XIAP/cIAP2 轴抵抗 DNA 损伤诱导的细胞凋亡,并且 IAP 拮抗剂使突变淋巴瘤对化疗药物敏感。
Cell Death Dis. 2023 Sep 8;14(9):599. doi: 10.1038/s41419-023-06122-2.
4
The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition.肿瘤抑制蛋白TRAF3调节糖原合成酶激酶3(GSK3)的活性以及B淋巴瘤细胞对GSK3抑制的敏感性。
Cancers (Basel). 2022 Oct 14;14(20):5029. doi: 10.3390/cancers14205029.
5
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets.里氏综合征:从分子发病机制到可成药靶点
Cancers (Basel). 2022 Sep 24;14(19):4644. doi: 10.3390/cancers14194644.
6
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.犬弥漫性大 B 细胞淋巴瘤的基因组图谱确定了具有临床和治疗意义的不同亚型。
Lab Anim (NY). 2022 Jul;51(7):191-202. doi: 10.1038/s41684-022-00998-x. Epub 2022 Jun 20.
7
MicroRNA-1226-3p has a tumor-promoting role in osteosarcoma.微小RNA-1226-3p在骨肉瘤中具有促肿瘤作用。
Oncol Lett. 2021 Jun;21(6):474. doi: 10.3892/ol.2021.12735. Epub 2021 Apr 15.
8
Interception Targets of Nakai Root Extract versus Pyranocoumarins in Prostate Early Lesions and Neuroendocrine Carcinomas in TRAMP Mice.Nakai 根提取物与吡喃香豆素类化合物在 TRAMP 小鼠前列腺早期病变和神经内分泌癌中的作用靶点。
Cancer Prev Res (Phila). 2021 Jun;14(6):635-648. doi: 10.1158/1940-6207.CAPR-20-0589. Epub 2021 Mar 1.
9
TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.肿瘤坏死因子受体相关因子 3 抑制正常和恶性 B 细胞中的 B 细胞受体信号转导。
J Biol Chem. 2021 Jan-Jun;296:100465. doi: 10.1016/j.jbc.2021.100465. Epub 2021 Feb 25.
10
The role of Pim kinase in immunomodulation.Pim激酶在免疫调节中的作用。
Am J Cancer Res. 2020 Dec 1;10(12):4085-4097. eCollection 2020.
F1000Res. 2017 Dec 18;6:2142. doi: 10.12688/f1000research.12880.1. eCollection 2017.
4
The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.致癌膜蛋白LMP1在B细胞淋巴瘤细胞中隔离TRAF3,导致功能性TRAF3缺陷。
Blood Adv. 2017 Dec 18;1(27):2712-2723. doi: 10.1182/bloodadvances.2017009670. eCollection 2017 Dec 26.
5
TRAF3 deficiency promotes metabolic reprogramming in B cells.TRAF3 缺乏促进 B 细胞的代谢重编程。
Sci Rep. 2016 Oct 18;6:35349. doi: 10.1038/srep35349.
6
TRAF3 as a powerful and multitalented regulator of lymphocyte functions.TRAF3作为淋巴细胞功能的强大且多才多艺的调节因子。
J Leukoc Biol. 2016 Nov;100(5):919-926. doi: 10.1189/jlb.2MR0216-063R. Epub 2016 May 6.
7
Nuclear TRAF3 is a negative regulator of CREB in B cells.细胞核内的肿瘤坏死因子受体相关因子3(TRAF3)是B细胞中cAMP反应元件结合蛋白(CREB)的负调控因子。
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):1032-7. doi: 10.1073/pnas.1514586113. Epub 2016 Jan 11.
8
The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.衔接蛋白TRAF3抑制B细胞中的白细胞介素-6受体信号传导,以限制浆细胞的发育。
Sci Signal. 2015 Sep 1;8(392):ra88. doi: 10.1126/scisignal.aaa5157.
9
Targeting the Pim kinases in multiple myeloma.靶向多发性骨髓瘤中的Pim激酶。
Blood Cancer J. 2015 Jul 17;5(7):e325. doi: 10.1038/bcj.2015.46.
10
Conditional Deletion of NF-κB-Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation.成年小鼠中NF-κB诱导激酶(NIK)的条件性缺失会破坏成熟B细胞的存活和激活。
J Immunol. 2015 Aug 1;195(3):953-64. doi: 10.4049/jimmunol.1401514. Epub 2015 Jun 26.